Correlation Between Quadrise Plc and ImmuPharma PLC

Can any of the company-specific risk be diversified away by investing in both Quadrise Plc and ImmuPharma PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quadrise Plc and ImmuPharma PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quadrise Plc and ImmuPharma PLC, you can compare the effects of market volatilities on Quadrise Plc and ImmuPharma PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quadrise Plc with a short position of ImmuPharma PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quadrise Plc and ImmuPharma PLC.

Diversification Opportunities for Quadrise Plc and ImmuPharma PLC

-0.88

Correlation Coefficient

Quadrise Plc  ImmuPharma PLC

Pay attention - limited upside

The 3 months correlation between Quadrise and ImmuPharma is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding Quadrise Plc and ImmuPharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmuPharma PLC and Quadrise Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quadrise Plc are associated (or correlated) with ImmuPharma PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmuPharma PLC has no effect on the direction of Quadrise Plc i.e., Quadrise Plc and ImmuPharma PLC go up and down completely randomly.

Pair Corralation between Quadrise Plc and ImmuPharma PLC

Assuming the 90 days trading horizon Quadrise Plc is expected to generate 2.28 times more return on investment than ImmuPharma PLC. However, Quadrise Plc is 2.28 times more volatile than ImmuPharma PLC. It trades about 0.27 of its potential returns per unit of risk. ImmuPharma PLC is currently generating about -0.16 per unit of risk. If you would invest  170.00  in Quadrise Plc on September 23, 2024 and sell it today you would earn a total of  358.00  from holding Quadrise Plc or generate 210.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Quadrise Plc  vs.  ImmuPharma PLC

Quadrise Plc

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Quadrise Plc are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Quadrise Plc exhibited solid returns over the last few months and may actually be approaching a breakup point.

ImmuPharma PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ImmuPharma PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Quadrise Plc and ImmuPharma PLC

The main advantage of trading using opposite Quadrise Plc and ImmuPharma PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quadrise Plc position performs unexpectedly, ImmuPharma PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmuPharma PLC will offset losses from the drop in ImmuPharma PLC's long position.

The idea behind Quadrise Plc and ImmuPharma PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.